Hardware Tiering and AI Coaching: How Google's Fitbit Edge Reshapes Continuous Monitoring Economics
Dr. Dereck Mush, MD, MBA
Biofourmis
Provides AI driven remote monitoring and digital therapeutics to manage patients at home.
What they do
Biofourmis develops platform software that uses artificial intelligence to monitor patients remotely. The platform collects physiological data from wearable devices to predict clinical decompensation, enabling early intervention by healthcare providers for conditions like heart failure.
The record
- Vertical
- Remote Monitoring & Wearables
- Sub-segment
- Remote patient monitoring
- Product type
- Platform software
- Stage
- Series C+
- Headquarters
- Boston, United States
- Region
- North America
- Founded
- 2015
- Total funding
- $330M raised
Notable investors: SoftBank Vision Fund 2, General Atlantic, CVS Health, Sequoia Capital India.
Also in Remote Monitoring & Wearables
Related on The Signal
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
The Top Remote Patient Monitoring Platforms of 2026
A hospital bed is the most expensive real estate in medicine. These seven platforms are moving serious care into the living room, and getting paid for it.
Dr. Dereck Mush, MD, MBA
From Remote Telemetry to Active Co-Management: Direct-to-Patient Hemodynamics in Heart Failure
Dr. Dereck Mush, MD, MBA
The 2026 CPT Code Changes for Remote Monitoring: What They Mean for Your Reimbursement Model
Dr. Dereck Mush, MD, MBA